We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Merrimack

News List

Merrimack to reduce workforce by 60 percent as ends development of cancer drug MM-121 firstwordpharma
November 09, 2018
Merrimack Pharmaceuticals announced plans to initiate a corporate restructuring that will see the drugmaker reduce expenses and slash its workforce by approximately...
Merrimack Pharmaceuticals Expands Phase II Lung Cancer Study biospace
March 13, 2018
Merrimack Pharmaceuticals Inc. saw a slight uptick in pre-market trading this morning after the company announced it is expanding enrollment in a Phase II lung cancer study.
Merrimack Appoints Head of Research contractpharma
April 18, 2017
Daryl Drummond, Ph.D. has been appointed head of research at Merrimack Pharmaceuticals. Dr. Drummond has expertise in the field of nanotherapeutics and has held various leadership roles at Merrimack
Merrimack initiates Phase 1 study of MM-310 in solid tumours europeanpharmaceuticalreview
March 30, 2017
Merrimack Pharmaceuticals have enrolled its first patient in a Phase 1 study of MM-310 in solid tumours.